Gene × Environment Interactions: From Molecular Mechanisms to Behavior

&NA; Gene‐by‐environment interactions (G×Es) can provide important biological insights into psychiatric disorders and may consequently have direct clinical implications. In this review, we begin with an overview of the major challenges G×E studies have faced (e.g., difficulties replicating findings and high false discovery rates). In light of these challenges, this review focuses on describing examples in which we might begin to understand G×Es on the molecular, cellular, circuit, and behavioral level and link this interaction to altered risk for the development of psychiatric disorders. We also describe recent studies that utilize a polygenic approach to examine G×Es. Finally, we discuss how gaining a deeper understanding of G×Es may translate into a therapeutic practice with more targeted treatments.

[1]  B. Bradley,et al.  Gene × Environment Determinants of Stress- and Anxiety-Related Disorders. , 2016, Annual review of psychology.

[2]  A. Serretti,et al.  Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy , 2012, European Neuropsychopharmacology.

[3]  V. Campbell,et al.  Tetrahydrocannabinol‐induced neurotoxicity depends on CB1 receptor‐mediated c‐Jun N‐terminal kinase activation in cultured cortical neurons , 2003, British journal of pharmacology.

[4]  J. Girault,et al.  Cannabinoids activate p38 mitogen‐activated protein kinases through CB1 receptors in hippocampus , 2001, Journal of neurochemistry.

[5]  T. Wassink,et al.  Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia , 2011, Schizophrenia Research.

[6]  C. Pariante,et al.  The Interface of Stress and the HPA Axis in Behavioural Phenotypes of Mental Illness. , 2014, Current topics in behavioral neurosciences.

[7]  A. Hariri,et al.  FKBP5 and emotional neglect interact to predict individual differences in amygdala reactivity , 2012, Genes, brain, and behavior.

[8]  Martin H. Schmidt,et al.  Interaction between the 5-HTTLPR serotonin transporter polymorphism and environmental adversity for mood and anxiety psychopathology: evidence from a high-risk community sample of young adults. , 2009, The international journal of neuropsychopharmacology.

[9]  A. Serretti,et al.  Interaction between SERTPR and stressful life events on response to antidepressant treatment , 2007, European Neuropsychopharmacology.

[10]  D. Picard,et al.  The glucocorticoid responses are shaped by molecular chaperones , 2007, Molecular and Cellular Endocrinology.

[11]  T. Grange,et al.  Glucocorticoid‐induced DNA demethylation and gene memory during development , 2001, The EMBO journal.

[12]  J. Romero,et al.  Functional neuroanatomy of the endocannabinoid system , 2005, Pharmacology Biochemistry and Behavior.

[13]  S. Galea,et al.  The serotonin transporter genotype and social support and moderation of posttraumatic stress disorder and depression in hurricane-exposed adults. , 2007, The American journal of psychiatry.

[14]  L. Price,et al.  Interaction of Childhood Maltreatment with the Corticotropin-Releasing Hormone Receptor Gene: Effects on Hypothalamic-Pituitary-Adrenal Axis Reactivity , 2009, Biological Psychiatry.

[15]  G. Alpers,et al.  Allelic variation in CRHR1 predisposes to panic disorder: evidence for biased fear processing , 2016, Molecular Psychiatry.

[16]  E. Binder,et al.  Gene–Stress–Epigenetic Regulation of FKBP5: Clinical and Translational Implications , 2016, Neuropsychopharmacology.

[17]  M. Kanehisa,et al.  FKBP5 is associated with amygdala volume in the human brain and mood state: A voxel-based morphometry (VBM) study , 2016, International journal of psychiatry in clinical practice.

[18]  F. Holsboer,et al.  FK506 Binding Protein 5 Shapes Stress Responsiveness: Modulation of Neuroendocrine Reactivity and Coping Behavior , 2011, Biological Psychiatry.

[19]  E. R. Sánchez,et al.  A New First Step in Activation of Steroid Receptors , 2002, The Journal of Biological Chemistry.

[20]  A. Danese,et al.  Childhood maltreatment and unfavourable clinical outcomes in bipolar disorder: a systematic review and meta-analysis. , 2016, The lancet. Psychiatry.

[21]  B. Franke,et al.  The serotonin transporter gene polymorphism 5-HTTLPR moderates the effects of stress on attention-deficit/hyperactivity disorder. , 2014, Journal of child psychology and psychiatry, and allied disciplines.

[22]  M. Rietschel,et al.  Interaction between serotonin transporter gene variants and life events predicts response to antidepressants in the GENDEP project , 2011, The Pharmacogenomics Journal.

[23]  A. Serretti,et al.  Pharmacogenetics in major depression: A comprehensive meta-analysis , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[24]  Peter Kraft,et al.  Finding the missing gene–environment interactions , 2015, European Journal of Epidemiology.

[25]  C. Hammen,et al.  Sensitizing effect of early adversity on depressive reactions to later proximal stress: Moderation by polymorphisms in serotonin transporter and corticotropin releasing hormone receptor genes in a 20-year longitudinal study , 2014, Development and Psychopathology.

[26]  A. Danese,et al.  Childhood maltreatment predicts unfavorable course of illness and treatment outcome in depression: a meta-analysis. , 2011, The American journal of psychiatry.

[27]  D. Storm,et al.  Hippocampal Neurotoxicity of Δ9-Tetrahydrocannabinol , 1998, The Journal of Neuroscience.

[28]  S. Armeli,et al.  The 5‐HTTLPR polymorphism moderates the effect of stressful life events on drinking behavior in college students of African descent , 2012, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[29]  C. Beevers,et al.  Serotonin transporter (5-HTTLPR) genotype, childhood abuse, and suicide attempts in adult psychiatric inpatients. , 2006, Suicide & life-threatening behavior.

[30]  K. Ressler,et al.  Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. , 2008, JAMA.

[31]  Peter Kraft,et al.  Challenges and opportunities in genome-wide environmental interaction (GWEI) studies , 2012, Human Genetics.

[32]  P. McGuire,et al.  Effect of cannabis on glutamate signalling in the brain: A systematic review of human and animal evidence , 2016, Neuroscience & Biobehavioral Reviews.

[33]  P. Zandi,et al.  Polygenic risk, stressful life events and depressive symptoms in older adults: a polygenic score analysis , 2014, Psychological Medicine.

[34]  N. Freimer,et al.  5‐HTTLPR genotype and anxiety‐related personality traits: A meta‐analysis and new data , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[35]  K. Lesch,et al.  Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory Region , 1996, Science.

[36]  Matthew C Keller,et al.  A critical review of the first 10 years of candidate gene-by-environment interaction research in psychiatry. , 2011, The American journal of psychiatry.

[37]  J. P. Hamilton,et al.  Neural Substrates of Increased Memory Sensitivity for Negative Stimuli in Major Depression , 2008, Biological Psychiatry.

[38]  Steven Lippmann,et al.  Chronic schizophrenia. , 1995, Postgraduate medicine.

[39]  Shelley E. Taylor,et al.  5-HTTLPR moderates effects of current life events on neuroticism: Differential susceptibility to environmental influences , 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[40]  D. Collier,et al.  Neurotrophic gene polymorphisms and response to psychological therapy , 2012, Translational Psychiatry.

[41]  M. Gill,et al.  Single-Nucleotide Polymorphism of the FKBP5 Gene and Childhood Maltreatment as Predictors of Structural Changes in Brain Areas Involved in Emotional Processing in Depression , 2016, Neuropsychopharmacology.

[42]  J. Bukszár,et al.  Catechol-O-Methyltransferase Contributes to Genetic Susceptibility Shared Among Anxiety Spectrum Phenotypes , 2008, Biological Psychiatry.

[43]  A. Kersting,et al.  Serotonergic genes modulate amygdala activity in major depression , 2007, Genes, brain, and behavior.

[44]  B. Bradley,et al.  Effect of Childhood Trauma on Adult Depression and Neuroendocrine Function: Sex-Specific Moderation by CRH Receptor 1 Gene , 2009, Front. Behav. Neurosci..

[45]  Xianzhang Hu,et al.  Interaction between Childhood Trauma and Serotonin Transporter Gene Variation in Suicide , 2007, Neuropsychopharmacology.

[46]  Hidehiro Iida,et al.  The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia. , 2006, Brain : a journal of neurology.

[47]  Catie Chang,et al.  Effects of salience-network-node neurofeedback training on affective biases in major depressive disorder , 2016, Psychiatry Research: Neuroimaging.

[48]  P. Muglia,et al.  Genome-wide pharmacogenetics of antidepressant response in the GENDEP project. , 2010, The American journal of psychiatry.

[49]  Tricia Z. King,et al.  STRUCTURAL AND FUNCTIONAL CONNECTIVITY IN POSTTRAUMATIC STRESS DISORDER: ASSOCIATIONS WITH FKBP5 , 2016, Depression and anxiety.

[50]  A M McIntosh,et al.  Neuroimaging and molecular genetics of schizophrenia: pathophysiological advances and therapeutic potential , 2008, British journal of pharmacology.

[51]  M. Beauregard,et al.  Early impact of 5-HTTLPR polymorphism on the neural correlates of sadness , 2010, Neuroscience Letters.

[52]  G. Jenkins,et al.  A Genomewide Association Study of Citalopram Response in Major Depressive Disorder , 2010, Biological Psychiatry.

[53]  R. Bryant,et al.  FKBP5 risk alleles and the development of intrusive memories , 2015, Neurobiology of Learning and Memory.

[54]  Gerhard Andersson,et al.  The COMTval158met polymorphism is associated with symptom relief during exposure-based cognitive-behavioral treatment in panic disorder , 2010, BMC psychiatry.

[55]  S. Langenecker,et al.  Variation in the Corticotropin-Releasing Hormone Receptor 1 (CRHR1) Gene Influences fMRI Signal Responses during Emotional Stimulus Processing , 2012, The Journal of Neuroscience.

[56]  Jay Belsky,et al.  For Better and For Worse , 2007 .

[57]  D. Cicchetti,et al.  Interactive effects of corticotropin releasing hormone receptor 1, serotonin transporter linked polymorphic region, and child maltreatment on diurnal cortisol regulation and internalizing symptomatology , 2011, Development and Psychopathology.

[58]  A. Caspi,et al.  Protective effect of CRHR1 gene variants on the development of adult depression following childhood maltreatment: replication and extension. , 2009, Archives of general psychiatry.

[59]  L. Selemon,et al.  BA11 FKBP5 expression levels correlate with dendritic spine density in postmortem PTSD and controls , 2015, Neurobiology of Stress.

[60]  D. Collier,et al.  Therapygenetics: The 5HTTLPR and response to psychological therapy , 2011, Molecular Psychiatry.

[61]  B. Merriman,et al.  Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican-Americans , 2004, Molecular Psychiatry.

[62]  J. Belsky,et al.  Take your mind off it: Coping style, serotonin transporter linked polymorphic region genotype (5-HTTLPR), and children's internalizing and externalizing problems , 2015, Development and Psychopathology.

[63]  P. Joyce,et al.  Childhood neglect and abuse as predictors of antidepressant response in adult depression , 2009, Depression and anxiety.

[64]  Florian Holsboer,et al.  The Corticosteroid Receptor Hypothesis of Depression , 2000, Neuropsychopharmacology.

[65]  Sven Andréasson,et al.  CANNABIS AND SCHIZOPHRENIA A Longitudinal Study of Swedish Conscripts , 1987, The Lancet.

[66]  K. Ressler,et al.  GENOME‐WIDE ASSOCIATION STUDY (GWAS) AND GENOME‐WIDE BY ENVIRONMENT INTERACTION STUDY (GWEIS) OF DEPRESSIVE SYMPTOMS IN AFRICAN AMERICAN AND HISPANIC/LATINA WOMEN , 2016, Depression and anxiety.

[67]  Michael F Egan,et al.  A susceptibility gene for affective disorders and the response of the human amygdala. , 2005, Archives of general psychiatry.

[68]  M C O'Donovan,et al.  The catechol-O-methyl transferase (COMT) gene as a candidate for psychiatric phenotypes: evidence and lessons , 2006, Molecular Psychiatry.

[69]  S. Beach,et al.  Prevention effects moderate the association of 5-HTTLPR and youth risk behavior initiation: gene x environment hypotheses tested via a randomized prevention design. , 2009, Child development.

[70]  A. Pickles,et al.  Annual Research Review: Threats to the validity of child psychiatry and psychology. , 2016, Journal of child psychology and psychiatry, and allied disciplines.

[71]  N. Schork,et al.  Gene-by-Environment (Serotonin Transporter and Childhood Maltreatment) Interaction for Anxiety Sensitivity, an Intermediate Phenotype for Anxiety Disorders , 2008, Neuropsychopharmacology.

[72]  Differential Responses to Psychotherapy Versus Pharmacotherapy in Patients With Chronic Forms of Major Depression and Childhood Trauma , 2005 .

[73]  Eliza Congdon,et al.  Neural correlates of epigenesis , 2006, Proceedings of the National Academy of Sciences.

[74]  L. Fañanás,et al.  Psychosis‐inducing effects of cannabis are related to both childhood abuse and COMT genotypes , 2014, Acta psychiatrica Scandinavica.

[75]  K. Aitchison,et al.  Pharmacogenetics of antidepressant response , 2011, Expert review of neurotherapeutics.

[76]  A. Toga,et al.  FKBP5 and attention bias for threat: associations with hippocampal function and shape. , 2013, JAMA psychiatry.

[77]  E. Rabiner,et al.  Does cannabis affect dopaminergic signaling in the human brain? A systematic review of evidence to date , 2015, European Neuropsychopharmacology.

[78]  Stephan Ripke,et al.  Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies. , 2013, The American journal of psychiatry.

[79]  R. Straub,et al.  Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[80]  J. Ormel,et al.  Differential susceptibility in youth: evidence that 5-HTTLPR x positive parenting is associated with positive affect ‘for better and worse' , 2011, Translational Psychiatry.

[81]  G. Kenis,et al.  Therapygenetics: 5-HTTLPR genotype predicts the response to exposure therapy for agoraphobia , 2014, European Neuropsychopharmacology.

[82]  Bradley N Gaynes,et al.  What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression. , 2009, Psychiatric services.

[83]  S. Kapur Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. , 2003, The American journal of psychiatry.

[84]  W. Vale,et al.  Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin , 1981 .

[85]  Georgia Koppe,et al.  Interaction of the Serotonin Transporter-Linked Polymorphic Region and Environmental Adversity: Increased Amygdala-Hypothalamus Connectivity as a Potential Mechanism Linking Neural and Endocrine Hyperreactivity , 2012, Biological Psychiatry.

[86]  Ahmad R. Hariri,et al.  Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. , 2010, The American journal of psychiatry.

[87]  David Goldman,et al.  Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. , 2006, American journal of human genetics.

[88]  K. Ressler,et al.  Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene. , 2008, Archives of general psychiatry.

[89]  R. Niesink,et al.  Does Cannabidiol Protect Against Adverse Psychological Effects of THC? , 2013, Front. Psychiatry.

[90]  R. Ophoff,et al.  The effect of childhood maltreatment and cannabis use on adult psychotic symptoms is modified by the COMT Val158Met polymorphism , 2013, Schizophrenia Research.

[91]  Shelley E. Taylor,et al.  Early Family Environment, Current Adversity, the Serotonin Transporter Promoter Polymorphism, and Depressive Symptomatology , 2006, Biological Psychiatry.

[92]  C. Nemeroff,et al.  The CRF system, stress, depression and anxiety—insights from human genetic studies , 2010, Molecular Psychiatry.

[93]  T. Rubino,et al.  Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models , 2010, British journal of pharmacology.

[94]  C. Spencer,et al.  Biological Insights From 108 Schizophrenia-Associated Genetic Loci , 2014, Nature.

[95]  T. Powles,et al.  Cannabis-induced cytotoxicity in leukemic cell lines: the role of the cannabinoid receptors and the MAPK pathway. , 2005, Blood.

[96]  Bart van der Burg,et al.  Glucocorticoid-induced increase in lymphocytic FKBP51 messenger ribonucleic acid expression: a potential marker for glucocorticoid sensitivity, potency, and bioavailability. , 2003, The Journal of clinical endocrinology and metabolism.

[97]  G. Koob,et al.  Corticotropin-releasing factor, norepinephrine, and stress , 1999, Biological Psychiatry.

[98]  Kymberly D. Young,et al.  Real-Time fMRI Neurofeedback Training of Amygdala Activity in Patients with Major Depressive Disorder , 2014, PloS one.

[99]  J. Sanjuán,et al.  Interaction between COMT haplotypes and cannabis in schizophrenia: A case-only study in two samples from Spain , 2011, Schizophrenia Research.

[100]  N. Wray,et al.  Genetic Differences in the Immediate Transcriptome Response to Stress Predict Risk-Related Brain Function and Psychiatric Disorders , 2015, Neuron.

[101]  M. Hauser,et al.  An Examination of the Association between 5-HTTLPR, Combat Exposure, and PTSD Diagnosis among U.S. Veterans , 2015, PloS one.

[102]  W. Vale,et al.  CRF and CRF receptors: role in stress responsivity and other behaviors. , 2004, Annual review of pharmacology and toxicology.

[103]  Avshalom Caspi,et al.  Gene-environment interplay and psychopathology: multiple varieties but real effects. , 2006, Journal of child psychology and psychiatry, and allied disciplines.

[104]  B. Bradley,et al.  Allele-specific FKBP5 DNA demethylation mediates gene–childhood trauma interactions , 2012, Nature Neuroscience.

[105]  A. Caspi,et al.  Influence of Life Stress on Depression: Moderation by a Polymorphism in the 5-HTT Gene , 2003, Science.

[106]  M. Rietschel,et al.  Role of FKBP5 in emotion processing: results on amygdala activity, connectivity and volume , 2014, Brain Structure and Function.

[107]  K. Ressler,et al.  Dexamethasone Treatment Leads to Enhanced Fear Extinction and Dynamic Fkbp5 Regulation in Amygdala , 2016, Neuropsychopharmacology.

[108]  M. Owen,et al.  Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use , 2007, British Journal of Psychiatry.

[109]  N. Risch,et al.  Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. , 2009, JAMA.

[110]  Stephan Ripke,et al.  A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression. , 2009, Archives of general psychiatry.

[111]  J. Belsky,et al.  Child exposure to serious life events, COMT, and aggression: Testing differential susceptibility theory. , 2015, Developmental psychology.

[112]  A. Meyer-Lindenberg,et al.  5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression , 2005, Nature Neuroscience.

[113]  Bettina Sorger,et al.  Real-Time Self-Regulation of Emotion Networks in Patients with Depression , 2012, PloS one.

[114]  R. Uher,et al.  Gene–Environment Interaction in Major Depression and Antidepressant Treatment Response , 2012, Current Psychiatry Reports.

[115]  F. Holsboer,et al.  Polymorphisms in the FKBP5 gene region modulate recovery from psychosocial stress in healthy controls , 2008, The European journal of neuroscience.

[116]  Thomas Meitinger,et al.  Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment , 2004, Nature Genetics.

[117]  M. Owen,et al.  Cannabis, COMT and psychotic experiences , 2011, British Journal of Psychiatry.

[118]  A. Caspi,et al.  Moderation of the Effect of Adolescent-Onset Cannabis Use on Adult Psychosis by a Functional Polymorphism in the Catechol-O-Methyltransferase Gene: Longitudinal Evidence of a Gene X Environment Interaction , 2005, Biological Psychiatry.

[119]  J. Potash,et al.  Polygenic interactions with environmental adversity in the aetiology of major depressive disorder , 2015, Psychological Medicine.

[120]  Yiyun Huang,et al.  Serotonin Transporter Availability in Patients with Schizophrenia: A Positron Emission Tomography Imaging Study with [11C]DASB , 2005, Biological Psychiatry.

[121]  Birgit Funke,et al.  COMT genetic variation confers risk for psychotic and affective disorders: a case control study , 2005, Behavioral and Brain Functions.

[122]  P. Sullivan,et al.  Effect of polygenic risk scores on depression in childhood trauma , 2014, British Journal of Psychiatry.

[123]  R. Ophoff,et al.  Cannabis use at a young age is associated with psychotic experiences , 2010, Psychological Medicine.

[124]  Marcus R. Munafò,et al.  Serotonin Transporter (5-HTTLPR) Genotype and Amygdala Activation: A Meta-Analysis , 2008, Biological Psychiatry.

[125]  Claes Wahlestedt,et al.  Personalized medicine in psychiatry: problems and promises , 2013, BMC Medicine.

[126]  Anja Schmitz,et al.  Gene–environment interactions predict cortisol responses after acute stress: Implications for the etiology of depression , 2009, Psychoneuroendocrinology.

[127]  Masanori Ichise,et al.  Serotonin Transporter Binding in Bipolar Disorder Assessed using [11C]DASB and Positron Emission Tomography , 2006, Biological Psychiatry.

[128]  Laura J. Scott,et al.  Joint Analysis of Psychiatric Disorders Increases Accuracy of Risk Prediction for Schizophrenia, Bipolar Disorder, and Major Depressive Disorder , 2015, American journal of human genetics.

[129]  P. Jensen Catechol O-Methyltransferase Gene Variant and Birth Weight Predict Early-Onset Antisocial Behavior in Children With Attention-Deficit/Hyperactivity Disorder , 2007 .

[130]  H. Mayberg,et al.  Stuck in a rut: rethinking depression and its treatment , 2011, Trends in Neurosciences.

[131]  C. Nemeroff Clinical significance of psychoneuroendocrinology in psychiatry: focus on the thyroid and adrenal. , 1989, The Journal of clinical psychiatry.

[132]  Tricia Z. King,et al.  FKBP5 Genotype and Structural Integrity of the Posterior Cingulum , 2014, Neuropsychopharmacology.

[133]  C. Donaldson,et al.  Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[134]  P. McGuffin,et al.  The moderation by the serotonin transporter gene of environmental adversity in the aetiology of mental illness: review and methodological analysis , 2008, Molecular Psychiatry.

[135]  Debashis Ghosh,et al.  Correcting systematic inflation in genetic association tests that consider interaction effects: application to a genome-wide association study of posttraumatic stress disorder. , 2014, JAMA psychiatry.

[136]  Jay Belsky,et al.  Beyond diathesis stress: differential susceptibility to environmental influences. , 2009, Psychological bulletin.

[137]  F. Wang,et al.  Meta-analysis of FKBP5 gene polymorphisms association with treatment response in patients with mood disorders , 2010, Neuroscience Letters.

[138]  S Beck,et al.  Epigenomics: genome-wide study of methylation phenomena. , 2002, Current issues in molecular biology.

[139]  A. Caspi,et al.  Protective Effect of CRHR 1 Gene Variants on the Development of Adult Depression Following Childhood Maltreatment Replication and Extension , 2009 .

[140]  M. Webster,et al.  Dysregulation of glucocorticoid receptor co-factors FKBP5, BAG1 and PTGES3 in prefrontal cortex in psychotic illness , 2013, Scientific Reports.

[141]  Peter W. Dillingham,et al.  An update on the interaction between the serotonin transporter promoter variant (5-HTTLPR), stress and depression, plus an exploration of non-confirming findings , 2014, Behavioural Brain Research.

[142]  P. Männistö,et al.  Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. , 1999, Pharmacological reviews.

[143]  C. Nievergelt,et al.  Genomic predictors of combat stress vulnerability and resilience in U.S. Marines: A genome-wide association study across multiple ancestries implicates PRTFDC1 as a potential PTSD gene , 2015, Psychoneuroendocrinology.

[144]  M. Stein,et al.  Interactive effect of stressful life events and the serotonin transporter 5-HTTLPR genotype on posttraumatic stress disorder diagnosis in 2 independent populations. , 2009, Archives of general psychiatry.

[145]  R Plomin,et al.  Gene–environment interaction analysis of serotonin system markers with adolescent depression , 2004, Molecular Psychiatry.

[146]  E. Binder,et al.  Expression and Regulation of the Fkbp5 Gene in the Adult Mouse Brain , 2011, PloS one.

[147]  A. Sawa,et al.  Environmental Stressors and Epigenetic Control of the Hypothalamic-Pituitary-Adrenal Axis , 2014, Neuroendocrinology.

[148]  T. Wassink,et al.  MAPK14 and CNR1 gene variant interactions: effects on brain volume deficits in schizophrenia patients with marijuana misuse , 2012, Psychological Medicine.

[149]  Major Depressive,et al.  A mega-analysis of genome-wide association studies for major depressive disorder , 2016 .

[150]  B. Lebowitz,et al.  Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. , 2006, The American journal of psychiatry.

[151]  Jim van Os,et al.  Reduced Cortical Thickness as an Outcome of Differential Sensitivity to Environmental Risks in Schizophrenia , 2011, Biological Psychiatry.

[152]  D. Kaufer,et al.  Glucocorticoids and the Brain: Neural Mechanisms Regulating the Stress Response. , 2015, Advances in experimental medicine and biology.

[153]  A. Serretti,et al.  The role of COMT gene variants in depression: Bridging neuropsychological, behavioral and clinical phenotypes , 2013, Neuroscience & Biobehavioral Reviews.

[154]  J. Ballenger The Serotonin Transporter Promoter Variant (5-HTTLPR), Stress, and Depression Meta-analysis Revisited: Evidence of Genetic Moderation , 2012 .

[155]  M. Daly,et al.  LD Score regression distinguishes confounding from polygenicity in genome-wide association studies , 2014, Nature Genetics.

[156]  J. Manzanares,et al.  Gene and protein alterations of FKBP5 and glucocorticoid receptor in the amygdala of suicide victims , 2013, Psychoneuroendocrinology.

[157]  U. John,et al.  Effect of the interaction between childhood abuse and rs1360780 of the FKBP5 gene on gray matter volume in a general population sample , 2016, Human brain mapping.

[158]  A. Caspi,et al.  Serotonin transporter gene moderates childhood maltreatment's effects on persistent but not single-episode depression: replications and implications for resolving inconsistent results. , 2011, Journal of affective disorders.

[159]  K. Lesch,et al.  Genetic contributions to acute autonomic stress responsiveness in children. , 2012, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

[160]  E. Binder,et al.  FKBP5 Allele-Specific Epigenetic Modification in Gene by Environment Interaction , 2015, Neuropsychopharmacology.

[161]  E. Weeber,et al.  A New Anti-Depressive Strategy for the Elderly: Ablation of FKBP5/FKBP51 , 2011, PloS one.

[162]  C. Anderson,et al.  Association between the serotonin transporter triallelic genotype and eating problems is moderated by the experience of childhood trauma in women. , 2012, The International journal of eating disorders.

[163]  Israel Liberzon,et al.  Genetic Association Analysis of 300 Genes Identifies a Risk Haplotype in SLC18A2 for Post-traumatic Stress Disorder in Two Independent Samples , 2014, Neuropsychopharmacology.

[164]  K. Kendler,et al.  Candidate Gene–Environment Interaction Research , 2015, Perspectives on psychological science : a journal of the Association for Psychological Science.

[165]  F. Holsboer,et al.  The involvement of FK506-binding protein 51 (FKBP5) in the behavioral and neuroendocrine effects of chronic social defeat stress , 2012, Neuropharmacology.

[166]  J. Hettema,et al.  Direct, indirect and pleiotropic effects of candidate genes on internalizing disorder psychopathology , 2015, Psychological Medicine.

[167]  V. Arango,et al.  A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. , 2000, Archives of general psychiatry.

[168]  K. W. Young,et al.  Neuropsin cleaves EphB2 in the amygdala to control anxiety , 2011, Nature.

[169]  Walter Heindel,et al.  5-HTTLPR Biases Amygdala Activity in Response to Masked Facial Expressions in Major Depression , 2008, Neuropsychopharmacology.

[170]  J. Smoller,et al.  Polymorphisms in FKBP5 are associated with peritraumatic dissociation in medically injured children , 2005, Molecular Psychiatry.

[171]  C. Flachskamm,et al.  Deficiency of FK506‐binding protein (FKBP) 51 alters sleep architecture and recovery sleep responses to stress in mice , 2014, Journal of sleep research.

[172]  F. Holsboer,et al.  Pharmacological Inhibition of the Psychiatric Risk Factor FKBP51 Has Anxiolytic Properties , 2015, The Journal of Neuroscience.

[173]  R. van Winkel Family-based analysis of genetic variation underlying psychosis-inducing effects of cannabis: sibling analysis and proband follow-up. , 2011, Archives of general psychiatry.

[174]  S. Galea,et al.  Modification of the association between serotonin transporter genotype and risk of posttraumatic stress disorder in adults by county-level social environment. , 2009, American journal of epidemiology.

[175]  F. Holsboer,et al.  FK506-binding Proteins 51 and 52 Differentially Regulate Dynein Interaction and Nuclear Translocation of the Glucocorticoid Receptor in Mammalian Cells* , 2005, Journal of Biological Chemistry.

[176]  Martin H. Schmidt,et al.  Moderating role of FKBP5 genotype in the impact of childhood adversity on cortisol stress response during adulthood , 2014, European Neuropsychopharmacology.